🟢 Tvardi Therapeutics is trading 6.5% up in after-hours trading

Tvardi Therapeutics is trading at $1.15, up 6.48% in after-hours trading; no clear catalyst was identified.

• The stock closed at $1.08 on October 6, after falling 5.26% in the regular session.
• Reports cited biotech-sector weakness and a decline in XBI during regular trading, which does not explain the after-hours rebound.
• Major U.S. indexes finished higher, but available evidence does not establish that broader market sentiment caused the move.